Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $795.41M.
ENTERPRISE VALUE (EV)
$795.41M
Kura Oncology, Inc.
Market Cap
$934.79M
Enterprise Value (EV)
$795.41M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Kura Oncology, Inc. (KURA) | $934.79M | $795.41M |
| Seaport Therapeutics, Inc. Common Stock (SPTX)vs › | $929.83M | $870.62M |
| CeriBell, Inc. (CBLL)vs › | $923.53M | $912.77M |
| MoonLake Immunotherapeutics (MLTX)vs › | $921.06M | $544.69M |
| Savara Inc. (SVRA)vs › | $952.91M | $941.22M |
| Aktis Oncology, Inc. (AKTS)vs › | $953.81M | $882.56M |
| HealthStream, Inc. (HSTM)vs › | $914.73M | $881.99M |
| Pacira BioSciences, Inc. (PCRX)vs › | $973.93M | $1.18B |
| Latigo Biotherapeutics Inc. (LTGO)vs › | $978.09M | N/A |
| Corvus Pharmaceuticals, Inc. (CRVS)vs › | $887.99M | $869.82M |
Market Cap
$934.79M
Total Debt
$9.71M
Cash
$149.10M
Enterprise Value
$795.41M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
